David Mullington

David Mullington is an accomplished professional with extensive experience in quality and regulatory affairs within the life sciences and pharmaceutical sectors. Currently serving as the VP of Quality and Regulatory Affairs at Sakura Finetek Europe since April 2025, David previously held notable positions such as Group Quality and Regulatory Affairs Director at Revvity from July 2021 to April 2025 and at Immunodiagnostic Systems (IDS) from May 2010 to April 2025. With a strong background in leading international teams, David has also worked with companies such as MilliporeSigma as Site Quality and Regulatory Affairs Manager, Piramal Pharma Solutions as Site Quality Manager, AstraZeneca as Site Quality Manager, and Sanofi in various quality roles. David holds a Bachelor of Science in Chemistry/Biochemistry from the University of Liverpool and a Master of Science in Analytical Chemistry from The University of Salford.